| CYSB2400245 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2024-09-14 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2000354 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-12-18 | 长春生物制品研究所有限责任公司 | Changchun Lnstitute of Biological Products Co Ltd | In Review | 2022-01-27 | view |
| CYSB2300186 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2023-10-19 | | Beijing Yuance Pharmaceutical Co Ltd | | | view |
| CYSB2400003 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2024-01-04 | | Changchun Lnstitute of Biological Products Co Ltd | | | view |
| CYSB2300188 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2023-10-19 | | Beijing Yuance Pharmaceutical Co Ltd | | | view |
| CYSB2300187 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2023-10-19 | | Beijing Yuance Pharmaceutical Co Ltd | | | view |
| CYSB2400244 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2024-09-14 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2000356 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-12-18 | 长春生物制品研究所有限责任公司 | Changchun Lnstitute of Biological Products Co Ltd | In Review | 2022-01-27 | view |
| CYSB2400002 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2024-01-04 | | Changchun Lnstitute of Biological Products Co Ltd | | | view |
| CYSB2400246 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2024-09-14 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2000355 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-12-18 | 长春生物制品研究所有限责任公司 | Changchun Lnstitute of Biological Products Co Ltd | In Review | 2022-01-27 | view |
| CYSB2400004 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2024-01-04 | | Changchun Lnstitute of Biological Products Co Ltd | | | view |
| CSB01069 | 注射用重组人干扰Α-2B | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Other | 2001-11-12 | 上海万兴生物制药有限公司 | Shanghai Wanxing Biological Pharmaceutical Co Ltd | Certificate Issued | 2002-09-18 | view |
| X0306833 | 注射用重组人干扰素a2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | New Drug Application | 2003-12-28 | 北京瑞得合通药业有限公司 | Beijing Ruide Hetong Pharmaceutical Co Ltd | Certificate Issued | 2005-01-27 | view |
| CSb01044 | 注射用重组人干扰素a2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products(2) | Supplementary Application | 2001-07-27 | 北京远策药业有限责任公司 | Beijing Yuance Pharmaceutical Co Ltd | Certificate Issued | 2001-11-14 | view |
| J0300686 | 注射用重组人干扰素α-2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | License Renew | 2004-05-13 | 先灵葆雅（欧洲）公司 | Schering-Plough Europe | Certificate Issued | 2005-02-02 | view |
| X0302914 | 注射用重组人干扰素α-2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | New Drug Application | 2003-06-12 | 海南通用同盟药业有限公司 | Hainan General Alliance Pharmaceutical Co Ltd | Certificate Issued | 2004-04-23 | view |
| CSS01002 | 注射用重组人干扰素α-2b（酵母） | Recombinant Human Interferon α2b | Lyophilized | Biological Products(2) | New Drug Application | 2001-01-22 | 复旦大学上海万兴生物制药有限公司 | | Certificate Issued | 2001-08-10 | view |
| CYSB2000401 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-12-29 | 北京远策药业有限责任公司 | Beijing Yuance Pharmaceutical Co Ltd | In Review | 2022-01-27 | view |
| CYSB1100254 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2011-11-01 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2013-01-10 | view |
